Trial · NCT06104631
A Prospective Trial in Patients With Crohn's Disease in Remission and Having Irritable Bowel Syndrome-like Symptoms
Crohn's disease is a chronic and complex inflammatory bowel disease affecting the gastrointestinal tract, causing symptoms like abdominal pain, diarrhea, and fa
- Status
- Recruiting
- Sponsor
- Biokuris s.a.
- Study type
- Interventional
- Phase
- No phase
- Enrollment
- 50 participants (planned)
- Start
- Mar 12, 2024
- Primary completion
- August 2025
- Conditions
- Irritable Bowel Syndrome-like Symptoms, Crohn Disease Remission
Summary
Crohn's disease is a chronic and complex inflammatory bowel disease affecting the gastrointestinal tract, causing symptoms like abdominal pain, diarrhea, and fatigue. While its exact cause is unclear, it involves genetic, environmental, and immunological factors. Crohn's disease can lead to nutrient deficiencies and has unpredictable flare-ups and remission periods. During the remission phases, irritable bowel syndrome (IBS)-like symptoms can persist in 50% of patients, for which no satisfactory treatment is available yet.
Interventions
- BK003 Other
- Placebo Other
Locations
2 countries: Belgium, France.
| Facility | City | Country |
|---|---|---|
| CHU Liege - Gastroenterology | Liège | Belgium |
| CHU Lille - Gastroenterology | Lille | France |
TreatIBS is an informational site and does not provide medical advice. The research summarized here may not apply to your situation. Talk with a clinician before starting, stopping, or changing any treatment.
Listing only. Eligibility is decided by the study team. TreatIBS is not involved in recruitment.